Goat anti-GALNS Antibody |
| Principle Name | GALNS |
| Official Symbol | GALNS |
| All Name and Symbols | GALNS; galactosamine (N-acetyl)-6-sulfate sulfatase (Morquio syndrome, mucopolysaccharidosis type IVA); GALNAC6S; GAS; MPS4A; N-acetylgalactosamine-6-sulfatase; chondroitinase |
| Accession Number(s) | NP_000503.1 |
| Peptide Sequence | TTHNLEDHTKLP, is from internal region |
| Human Gene ID(s) | 2588 |
| Non-Human GeneID(s) | |
| Important Comments | |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Supplied As | lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing. |
| Applications | Pep ELISA, WB |
| Tested Species | Human |
| Peptide ELISA | antibody detection limit dilution 1 to 64000. |
| Western Blot | Approx 60kDa band observed in Human Bone Marrow and Placenta lysates (calculated MW of 58.0kDa according to NP_000503.1). Recommended concentration |
| Reference(s) | Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci. 2006 Jul 12;26(28) |
